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Energy plans were normalized such that 95% of the PTV 
received the prescription dose. Once prescription was 
achieved, the doses to OARs, such as spinal cord, heart, 
esophagus, and healthy lungs were iteratively lowered until 
standard deviation of the dose across the PTV in each plan 
became less than 4%. Dose indices (DIs), such as DPTV95% (dose 
to 95% of the PTV), DCord1%, Desophagus50%, Dheart33%, Dlungs20%, 
Dlungs30%, and volume indices (VIs) such as Vlungs2000 cGy, and 
Vlungs3000 cGy were compared. The dosimetric differences among 
the DIs and the VIs were subjected to a two-tailed paired t-
test to determine the statistically significant dose differences 
(p < 0.05). 
Results: The table below summarizes statistically significant 
differences over all indices. Negative differences indicate 
lower doses/masses/integral doses with Energy optimization. 
On average the DIs and the VIs resulting from the Energy 
optimization are lower than the indices obtained with Dvh 
optimization. With very few exceptions this is true for each 
individual DI and VI. Notably, the total energy deposited in 
the entire volume outside of the target was on average lower 
for Energy optimization with statistically significant 
difference of 14.4%. The same was true for each patient, i.e. 
the integral dose outside of the PTV was always lower with 
energy optimization. 
Conclusions: It was found that in inverse planning Energy 
based optimization results in lower doses to nearby OARs. For 
identical target coverage Energy based plans resulted in 
statistically significant OAR sparing ranging from 18% to more 
than 80%.  
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Purpose/Objective: The aim of VoxTox is to establish 
delivered dose over a course of radiotherapy and its 
relationship with toxicity, in 1920 participants treated with 
Intensity Modulated IGRT for head and neck cancer, prostate 
cancer, or a central nervous system tumour. As part of the 
VoxTox project, we required a system for automatic 
recalculation of dose cubes, using the MV CT images acquired 
for IGRT on a TomoTherapy machine.  
Materials and Methods: We have developed a system that 
can be integrated within the GANGA computational-task 
management system originally developed for use on the 
ATLAS and LHCb experiments at CERN. We are extracting 
images, RTPLAN objects and daily set-up information from 
the TomoTherapy archive. Software has been developed in 
MatLab to calculate the delivered dose by applying the 
RTPLAN to the MV images (supplemented by the planning 
kVCT images where the MV dataset does not extend far 
enough). We have acquired data on the variation over 7 years 
of the HU calibration of the MV images. We combine the 
doses with rectal outlines determined from the MV images of 
prostate radiotherapy patients to produce dose surface maps 
(DSM).  
Results: To calculate dose on 128x128x22 calculation points, 
took 40.5 minutes in MatLab 2013b on an Intel Xeon 3.3 GHz 
with 8GB of RAM, using Windows 7. From 2007 to 2011 there 
was considerable variation in HU calibration within +/-30HU. 
Following the introduction of the dose-rate servo in 2011, 
and a new weekly calibration procedure in 2012, this is stable 
to better than +/-10HU. .  
The figure shows a typical rectal DSM summed over 37 
fractions; vertical axis is sup-inf, horizontal axis normalised 
circumference of rectum. The MV images did not extend the 
full length of the rectum, so this part has been determined 
from the planning kV CT. The join is feathered as a result of 
the fact that the superior and inferior margin of the MV 
images varies from day to day. 
For some patients the DSMs are similar to DSMs calculated 
from the original treatment plan, in some they show larger 
areas of high dose, in some they show smaller areas. 
 
 
Conclusions: We have developed a system for automatic dose 
recalculation of Tomotherapy dose distributions. This does 
not tie up the clinically-needed planning system, but can be 
run on a cluster of independent machines. Using the 
computational-task management system GANGA enables 
automation of the process. In conjunction with the ongoing 
collection of patient toxicities, this method of automatic 
recalculation will enable us to achieve the goals of VoxTox  
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Purpose/Objective: It is widely assumed that Monte Carlo 
(MC) methods produce the most accurate results in dose 
calculations problems but, due to their high computational 
cost, they are rarely used in routine radiotherapy (RT) 
treatment calculations. In this work a cloud-based solution 
for MC verification of RT treatments is presented.  
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Materials and Methods: A MC treatment verification solution 
was implemented on CloudMC, a cloud-based platform 
presented in a previous work. CloudMC runs on Windows 
Azure cloud platform and it had been developed following 
three basic principles: multi-application, elasticity and 
accessibility. It was first designed to parallelize simple MC 
simulations in as many virtual machines as the user selected. 
New features were now added to convert RT plan information 
into text MC input files and to merge the simulation output 
files into a DICOM format dose file that can be compared to 
the one obtained from the planning system. It was also 
necessary to develop a method to distribute the different 
treatment beams calculations among the different virtual 
machines. The MC programs used to perform the 
implementation study were BEAMnrc and DOSxyz, both based 
on the EGSnrc code. CloudMC is independent of the MC code 
used, i.e. the user may use any program based on any other 
MC code provided they fulfill some basic requirements. 
Several tests were carried out to study the times involved in 
the different parts of the process (virtual machines start-up, 
file transfer between machines and the storage system, map-
reduce methods, etc.) and the usage costs of the cloud 
computing resources. 
Results: A complete prostate treatment (25 segments 
distributed in 7 incidences) was simulated using 1.2E9 
primary histories from a 20GB IAEA phase space file. The 
calculation grid was 2x2x5 mm3. The final dose distribution 
had an statistical uncertainty below 1.5% (k=1) in the PTV 
volume. The parallelization was done in 190 small-size virtual 
machines (1 core, 2.2 Ghz, 1.75 GB RAM). The total 
calculation time was 1h and 30 minutes, from which 1h and 
10 min were spent in the MC simulation. The 190 virtual 
machines cluster is created and eliminated in each 
simulation. It needs a start up time that depends on the 
number and size of the machines. In this case, the start up 
time took 7 minutes. The management of the result files 
(2.7GB) was carried out in a medium-size machine. The time 
spent in downloading, merging and uploading the final result 
files was 3 min. The usage cost of this simulation was 15 €. 
Conclusions: The cloud-based application CloudMC has been 
updated with a new feature that allows performing MC 
verifications of RT treatments in a fast, cheap and easy way, 
accessible to any user. The computing power, accessibility 
and low costs make commercial clouds a suitable solution to 
bring MC algorithms closer to daily RT treatment 
calculations. 
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Purpose/Objective: The increasing number of survival 
radiotherapy patients has generated an emergent concern on 
second cancers risks, associated to peripheral doses. Out-of 
field dosimetry of photon and neutron components is still 
under development. Our group established a methodology for 
neutron equivalent dose estimation in organs [1]. In addition, 
an algorithm [2] has been implemented in Philips’ Pinnacle 
TPS for neutron peripheral dose estimation of patients, 
treated with high energy as a part or the totality of their 
treatment. The aim of this study was to present, as an 
example, neutron peripheral doses in pelvic radiotherapy 
treatments to show the high potential of this tool when 
choosing the optimal treatment. 
Materials and Methods: A self-developed Pinnacle script has 
been used for neutron peripheral dose estimation in thirteen 
relevant organs. This study was performed in two centres 
including 2 different machines (3 Siemens Primus and 1 
Siemens Oncor). All of them were previously characterized by 
following the methodology established in [3].  
Pelvic cases that contain high energy (15 or 18 MV) have been 
considered. As neutron doses strongly depend on MU, once 
the facility is characterized, dose estimations are done by 
considering the total number of MU (high energy) and 
choosing patient gender (male/female) and treatment 
location (abdomen/H&N). Population taken into account for 
this study is detailed in the table. Obtained results have been 
compared to previous values [2] where an important cohort 
of patients and machines from 50 facilities were evaluated. 
Table. (see text) 
 
 
Results: The figure shows mean equivalent doses at different 
out-of field organs (mSv) in pelvic (see table) and only 
rectum cases, due to peripheral neutrons from high energy 
radiotherapy treatments. Some representative organs, 
located far from the treatment region, have been considered 
to illustrate neutron peripheral doses. 
When comparing all the pelvic values to previous clinical 
studies [2], considering only the linacs and pathologies 
presented in this work, the mean deviation obtained for 
organ doses is 18%, in the range of uncertainties.  
Figure.  
